Candy Giant Mars collaborates with a biotech firm for Gene-Edit Cocoa Supply

Candy Maker Mars said he was cooperating with the Biotech Company pair on Wednesday to speed up the development of more elastic cocoa using Crispr-The technology of editing genes based on.

The agreement provides the M&M manufacturers to access the Fulcrum Pair Platform, which includes a plant of plant traits, and gives Mars the opportunity to adapt its yields to be stronger and stable.

Crispr is a tool to edit genes that make rapid and accurate changes to DNA. In agriculture, it is used to improve cultures, focusing on different features, such as drought and resistance to diseases.

The goal is to create cocoa-source cocoa-source, which are then fried and produced in cocoa, which can better withstand diseases, heat and other climates that can expose global chocolate.

In October, Starbucks Invested in Two innovative farms In Central America to protect the network coffee from global warming. Farms develop climatic sustainable coffee and test technologies such as drones and mechanization.

Edit genes allows for more quickly and precise development of features than traditional breeding said in A press -release.

In recent years, Crispr has attracted attention for its use in health care. At the end of 2023, the US Power Office approved the first Treatment of gene editing in sickle cell disease.

“On Mars, we believe that Crispr has the potential to improve the crop ways that support and strengthen global supply networks,” said Carl Jones, Director for Mars.

Last month, announced Candy Giant Investing $ 2 billion into US production by 2026. This includes new $ 240 million investments for the Nature Bakery in Utah.